<DOC>
	<DOCNO>NCT01375127</DOCNO>
	<brief_summary>This observational study design collect follow-up clinical date subject treat tofacitinib 2 complete Phase 2 study either discontinue treatment prematurely elect enroll long-term extension study .</brief_summary>
	<brief_title>Collection Follow-up Data From CP-690,550-treated Kidney Transplant Recipients</brief_title>
	<detailed_description>Subjects identify base whether receive tofacitinib 2 complete Phase 2 study either discontinue treatment prematurely elect enroll long-term extension study . Subjects pre-identified</detailed_description>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Subjects discontinue tofacitinib prior plan treatment duration 2 complete Phase 2 study ; enrol longterm extension study . No subject eligible study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Observational</keyword>
	<keyword>clinical follow-up data</keyword>
</DOC>